Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05533359 · ClinicalTrials.gov registry record · NA
SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 2,117
- Enrollment target
NCT05533359 is a NA study that has completed, run by University of Utah. The registered enrollment target is 2,117 participants.
The verdict
NCT05533359, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,117 participants
- Enrollment target
Study Summary
The long-term objective of SCALE-UP II is to increase the reach, uptake, and sustainability of COVID-19 testing among underserved populations. Through RADx-UP Phase I funding (SCALE-UP Utah), the team has established population health management (PHM) interventions that have been used since Feb 2021 to increase the uptake of COVID-19 testing and vaccination among community health center patients. Interventions are based on a PHM approach that uses widely available technology (i.e. cell phones and text messaging). SCALE-UP II will both build on SCALE-UP Utah PHM interventions and investigate novel resource conservation approaches (i.e., Request-Patient Navigation vs. No Patient Navigation and text messaging vs. conversational agent). SCALE-UP II builds on long standing partnerships among the University of Utah Clinical and Translational Science Institute (UofU CTSI), Association for Utah Community Health (AUCH), CHCs, and the Utah Department of Health(UDOH). CTSI and SCALE-UP II investigators are leading several COVID-19 initiatives that drive public health response and state government policies in Utah. Thus, the UofU team is uniquely positioned to lead this project.
Interventions
- BEHAVIORAL Patient Navigation (PN)
- BEHAVIORAL Text-Messaging (TM)
- BEHAVIORAL Conversational Agent (CA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,117 participants |
| Start Date | 2023-01-15 |
| Est. Completion | 2023-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05533359
The ClinicalTrials.gov registry entry for NCT05533359 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Patient Navigation (PN) is the first listed.
NCT05533359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05533359 about?
NCT05533359 is a clinical study titled "SCALE-UP Utah II: Community-Academic Partnership to Address COVID-19 Conversational Agent Study". The long-term objective of SCALE-UP II is to increase the reach, uptake, and sustainability of COVID-19 testing among underserved populations. Through RADx-UP Phase I funding (SCALE-UP Utah), the team has established population health management (PHM) interventions that have been used since Feb 2021...
What is the current status of trial NCT05533359?
This trial is currently completed. It is a NA study. The enrollment target is 2,117 participants. The study started on 2023-01-15. Estimated completion is 2023-11-30.
What interventions are being tested in trial NCT05533359?
The interventions under investigation include: Patient Navigation (PN) (BEHAVIORAL), Text-Messaging (TM) (BEHAVIORAL), Conversational Agent (CA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05533359?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.